(Q42213709)

18 October 2017

title

Cardiac Arrest during Dipyridamole Imaging (English)

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

31 December 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

31 December 2022

author name string

M. S. Blumenthal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3359832

31 December 2022

C. S. McCauley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3359832

31 December 2022

language of work or name

English

0 references

publication date

1 May 1988

1 reference

full work available at URL

18 October 2017

https://api.elsevier.com/content/article/PII:S0012369216310534?httpAccept=text/plain

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

https://api.elsevier.com/content/article/PII:S0012369216310534?httpAccept=text/xml

31 December 2022

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

31 December 2022

1 reference

18 October 2017

volume

93

1 reference

18 October 2017

issue

5

1 reference

18 October 2017

page(s)

1103-1104

1 reference

Noninvasive detection and localization of coronary stenoses in patients: comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imaging

18 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction

31 December 2022

2

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

Usefulness of oral dipyridamole suspension for stress thallium imaging without exercise in the detection of coronary artery disease

31 December 2022

3

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

Thallium-201 myocardial imaging during pharmacologic coronary vasodilation: comparison of oral and intravenous administration of dipyridamole

31 December 2022

4

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

Safety of intravenous dipyridamole for stress testing with thallium imaging

31 December 2022

5

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

Ventricular dysrhythmias following intravenous dipyridamole during "stress" myocardial imaging

31 December 2022

6

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial

31 December 2022

7

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

Evidence for intravenous dipyridamole (persantin) producing a "coronary steal" effect in the ischaemic myocardium.

31 December 2022

8

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

Dipyridamole-induced myocardial ischemia

31 December 2022

9

1 reference

https://api.crossref.org/works/10.1378/CHEST.93.5.1103

31 December 2022

Identifiers

1 reference

18 October 2017

1 reference